Search Within

Urvi A Shah

Formats
  1. Meeting Abstract (126)
  2. Journal Article (35)
  3. Research Letter (11)
  4. Review (9)
  5. Correspondence (3)
  6. Editorial (2)
Groups
  1. CTCR Scholars (186)
  2. Department of Medicine (186)
  3. Hematologic Malignancies, Division of (186)
  4. Center for Hematologic Malignancies (146)
  5. Myeloma (145)
  6. Hematologic Malignancies Research (140)

More Groups

People
  1. Alexander Lesokhin (136)
  2. Sham Mailankody (131)
  3. Malin Hultcrantz (125)
  4. Hani Hassoun (123)
  5. Neha Korde (123)
  6. Carlyn Rose Tan (112)

More People

Years
  1. 2025 (4)
  2. 2024 (38)
  3. 2023 (44)
  4. 2022 (44)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. Blood (66)
  2. Clinical Lymphoma, Myeloma and Leukemia (42)
  3. Journal of Clinical Oncology (15)
  4. Blood Cancer Journal (8)
  5. Blood Advances (6)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (72)
  2. Elsevier Inc. (51)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (13)
  5. American Association for Cancer Research (5)
  6. American Medical Association (4)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation improves survival in North American adult T-cell leukemia and lymphoma (NA-ATLL) with CNS involvement with minimal graft versus host disease (GVHD)
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Evaluation of potential predictors of central nervous system (CNS) involvement in North American adult T-cell leukemia lymphoma (ATLL) and their survival pattern
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
    Research Letter

    Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Nutrition perceptions, needs and practices among patients with plasma cell disorders
    Research Letter

    Malik, M. A.; Sweeney, N. W.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P. A.; Mailankody, S.; Korde, N.; Tan, C. R.; Hassoun, H.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta-analysis of randomized clinical trials
    Journal Article

    Das, A.; Dasgupta, S.; Gong, Y.; Shah, U. A.; Fradley, M. G.; Cheng, R. K.; Roy, B.; Guha, A.
    Hematological Oncology (2022)

    Fulltext@MSK | Save
  • A comprehensive review of the impact of obesity on plasma cell disorders
    Review

    Parikh, R.; Tariq, S. M.; Marinac, C. R.; Shah, U. A.
    Leukemia (2022)

    Fulltext@MSK | Save
  • Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
    Journal Article

    Piedra, K.; Peterson, T.; Tan, C.; Orozco, J.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Lesokhin, A.; Shah, U.; Lu, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
    Research Letter

    Shah, U. A.; Rögnvaldsson, S.; Derkach, A.; Björkholm, M.; Turesson, I.; David, Y.; Hultcrantz, M.; Tan, C.; Hassoun, H.; Korde, N.; more...
    Haematologica (2022)

    Fulltext@MSK | Save